What a Biomelogic mechanistic report looks like

• Gut barrier & motilityStrained

  Variable transit, post-meal distention.

• Mast-cell reactivityStrained

  Threshold-lowering pattern, not first-line activation.

• Energy / mitochondrial reserveStrained

  Post-prandial fatigue out of proportion to meal size.

• Autonomic regulationUncertain

  Orthostatic features not formally characterized.

• Microbiome compositionUncertain

  No recent stool-based profile available.

1. upstream
   Recurrent luminal disturbance

   Likely contributor to barrier perturbation; mechanism not fully characterized.

2. midstream
   Barrier perturbation

   Sustained low-grade barrier strain proposed as a permissive factor.

3. midstream
   Mast-cell threshold lowering

   Working hypothesis: barrier signal lowers degranulation threshold.

4. downstream
   Post-prandial fatigue

   Energy axis appears reactive to upstream load, not the primary lesion.

Within the Host Capacity Model, the picture reads as reduced post-prandial buffering capacity rather than a primary mast-cell or motility disorder. Capacity returns between exposures, which is consistent with strain rather than depletion.

• Primary motility disorder

  Bloating and post-meal symptoms driven by motility, with immune features secondary.

  For: Post-meal timing, distention pattern.
  Against: Reactivity tracks with food class, not meal volume alone.
• Primary mast-cell activation pattern

  Threshold-lowered mast-cell activation as the leading mechanism.

  For: Flushing, partial antihistamine response.
  Against: Reactivity is intermittent and food-class linked, not constitutive.
• Autonomic-led pattern

  Autonomic dysregulation drives gut symptoms downstream.

  For: Afternoon fatigue, possible orthostatic features.
  Against: Autonomic features have not been formally characterized.

• Is the gut driving the immune pattern, or vice versa?
  Side A · Barrier perturbation lowers mast-cell threshold (gut → immune).

  Side B · Underlying mast-cell pattern destabilizes barrier (immune → gut).

  Current reading: Working interpretation favors gut → immune given partial response to dietary structure changes; remains a hypothesis.

• Inflammation baseline
  hs-CRP · ferritin · ESR

  Markers within reference but trending toward upper-normal; consistent with low-grade strain, not active inflammation.

  Repeat during a symptomatic window for context.

• Iron / energy
  ferritin · transferrin saturation · B12 · homocysteine

  Suggests adequate substrate but reduced flexibility; not a primary deficiency picture.

  Consider repeat fasting after standardized intake.

• It does not establish a diagnosis.
• It does not establish causation between any single mechanism and symptom intensity.
• It does not predict an individual response to any intervention.

• Would a structured 14-day food-symptom log change the picture?
• Is there value in repeating tryptase / histamine during a symptomatic window?
• Would a basic autonomic assessment clarify the orthostatic signal?

• Timing of any motility study relative to symptom windows.
• Whether a stool-based profile is appropriate before further dietary structure changes.
• Coordination between GI and allergy/immunology to avoid duplicated workups.

• Re-baselining inflammation markers during a symptomatic window often clarifies whether strain is constant or episodic.
• A standardized barrier-relevant panel can help separate motility-led from immune-led readings.

• Educational mechanistic synthesis only — not diagnosis or care.
• Hypotheses are interpretive and revisable as new data arrives.
• Individual variation applies; this analysis does not predict outcomes.

• Energy / mitochondrial reserveDepleted

  Effort-out-of-proportion fatigue, slow recovery.

• Autonomic regulationStrained

  Orthostatic features, heart-rate lability.

• Mast-cell reactivityStrained

  Widening reactivity pattern; not first-line activation.

• Gut barrier & motilityStrained

  Food-class reactivity, variable transit.

• Microbiome compositionUncertain

  Old stool profile, unlikely current.

• Immune regulationUncertain

  Post-viral immune-set point not formally measured.

1. upstream
   Post-infectious immune perturbation

   Likely permissive contributor; mechanism not fully characterized.

2. midstream
   Autonomic destabilization

   Plausible amplifier of both gut and energy expression.

3. midstream
   Mast-cell threshold lowering

   Working hypothesis: post-infectious signaling lowers degranulation threshold.

4. midstream
   Barrier strain

   Sustained food-class reactivity consistent with barrier permeability shift.

5. downstream
   Energy-axis depletion

   Reactive depletion proposed; not the primary lesion.

6. downstream
   Cognitive fog

   Likely downstream of energy + autonomic load.

Within the Host Capacity Model, capacity does not return between exposures — a depletion picture rather than strain. Multiple axes appear to share the load, which is consistent with post-infectious multi-system recovery rather than a single primary lesion.

• Primary autonomic-led picture

  Autonomic dysregulation is the central mechanism; gut and immune features are downstream.

  For: Orthostatic features, heart-rate lability, fog timing.
  Against: Reactivity widening predates standing-related symptoms.
• Primary mast-cell pattern

  Threshold-lowered mast-cell activation is the central mechanism.

  For: Broadening food-class reactivity, partial antihistamine response.
  Against: Energy depletion exceeds expected mast-cell load.
• Primary energy-axis depletion

  Mitochondrial / energy depletion is the central mechanism; everything else is reactive.

  For: Effort-disproportionate fatigue, slow recovery, fog.
  Against: Food-class reactivity is poorly explained by energy axis alone.
• Distributed multi-axis pattern (working)

  No single primary lesion; load is shared across multiple axes after a post-infectious perturbation.

  For: All four axes show concurrent strain or depletion; pattern fits post-infectious recovery shape.
  Against: Less actionable; harder to test cleanly.

• Is autonomic involvement primary or downstream?
  Side A · Autonomic destabilization drives the picture.

  Side B · Autonomic features are downstream of energy depletion + mast-cell threshold shift.

  Current reading: Working interpretation is downstream, but autonomic measurement is missing.

• Did food reactivity precede the viral illness or follow it?
  Side A · Pre-existing food reactivity that worsened.

  Side B · New post-viral pattern.

  Current reading: Timeline favors post-viral broadening; pre-illness baseline is not well documented.

• Inflammation baseline
  hs-CRP · ferritin · ESR · fibrinogen

  Markers within reference; ferritin upper-normal. Consistent with low-grade chronic strain.

  Repeat in symptomatic vs quiet window.

• Energy substrate
  B12 · homocysteine · magnesium RBC · lactate

  Substrate adequate; flexibility appears reduced. Lactate not measured.

  Consider standardized fasting + post-load measurement.

• Autonomic-relevant
  supine/standing HR · blood pressure · morning cortisol

  Insufficient data to characterize.

  Basic standing protocol would clarify.

• Immune set-point
  lymphocyte subsets · immunoglobulins

  No recent panel; post-viral immune-set point unknown.

  Discuss with immunology before adding new layers.

• It does not establish a diagnosis.
• It does not establish that any axis is solely responsible.
• It does not predict an individual response to any intervention.
• It does not constitute a treatment plan.

• Would a basic supine/standing autonomic protocol change the central reading?
• Is there value in re-measuring immune set-point markers before adding new layers?
• Would a structured pacing window provide useful baseline data before further interventions?

• Coordination between immunology, cardiology (autonomic), and primary care to avoid contradictory recommendations.
• Sequencing: which axis to characterize first to reduce confounding.
• How to interpret partial responses to short trials.

• When multiple axes appear involved, characterizing the least-measured axis first usually yields the most interpretive lift.
• Repeat key markers in both symptomatic and quiet windows to separate constant vs episodic strain.

• Educational mechanistic synthesis only — not diagnosis or care.
• Multi-axis hypotheses are inherently lower-confidence than single-axis ones.
• Individual variation applies; this analysis does not predict outcomes.

• Microbiome compositionStrained

  Lower commensal diversity signals; opportunistic species in moderate range.

• Gut barrierUncertain

  Some indirect markers; no direct barrier panel submitted.

• Mitochondrial / energy pathwaysStrained

  Organic-acid pattern suggests reduced flexibility, not deficiency.

• Inflammation baselineSupportive

  CBC differential within reference, neutrophil-lymphocyte ratio unremarkable.

1. upstream
   Microbiome strain

   Likely contributor to barrier signaling; not solely diagnostic.

2. midstream
   Energy-pathway flexibility loss

   Reactive rather than primary depletion.

3. downstream
   Symptom pattern (per submission)

   Bloating, rashes, low energy plausibly downstream of the above.

Within the Host Capacity Model, the marker pattern reads as low-grade capacity strain. There is no evidence of acute or critical findings requiring urgent escalation; if symptoms worsen, contact your clinician.

• Primary microbiome dysbiosis pattern

  Microbiome composition is the central mechanism; energy markers are downstream.

  For: Diversity signals + opportunistic species range.
  Against: Single timepoint; stool variability is high.
• Primary energy-pathway pattern

  OAT pattern is the central finding; gut markers are coincidental.

  For: Reduced-flexibility pattern is consistent.
  Against: OAT alone does not establish causation.

• Does the GI-MAP pattern justify intervention without symptom correlation?
  Side A · Pattern is meaningful regardless of symptom intensity.

  Side B · Pattern requires symptom correlation to be actionable.

  Current reading: Educational reading favors symptom correlation; this is a clinician decision.

• GI-MAP highlights
  Commensal diversity index · Opportunistic group · Calprotectin (within reference)

  Pattern fits low-grade strain; not an acute inflammatory picture.

  Single timepoint — repeat consideration is a clinician decision.

• OAT highlights
  Krebs cycle intermediates · Fatty-acid oxidation markers · Neurotransmitter metabolites

  Reduced flexibility pattern; not a deficiency picture.

  Hydration and recent dietary state can shift several markers.

• CBC highlights
  Hemoglobin · MCV · Differential · Platelets

  Within reference; no flags requiring escalation.

  Standard hematology context only.

• It does not establish a diagnosis from labs.
• It does not justify any specific protocol.
• It does not replace your clinician's review of the same labs.

• Would symptom-paired retesting clarify whether the pattern is stable?
• Is a barrier-relevant panel useful before changing dietary structure?
• Are any of these markers worth repeating under standardized conditions?

• Whether GI-MAP findings warrant clinical follow-up given current symptom intensity.
• Whether OAT findings should be repeated under standardized intake.
• How to weight single-timepoint stool data.

• Pair stool-based markers with a symptom log over the same window.
• Repeat OAT under standardized fasting + intake conditions before drawing inferences.

• Educational marker-by-marker reading only — not diagnosis or care.
• No live session was requested, so context is limited to what was submitted.
• If lab values are flagged urgent by your laboratory, contact your clinician — not this report.